Need professional-grade analysis? Visit stockanalysis.com
$9.59B
18.96
2,028
N/A
Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY30.60, down 0.33% from the previous close.
Over the past year, 688076 has traded between a low of CNY28.42 and a high of CNY49.31. The stock has lost 16.2% over this period. It is currently 37.9% below its 52-week high.
Sinopep-Allsino Biopharmaceutical Co. Ltd. A has a market capitalization of $9.59B, with a price-to-earnings ratio of 18.96.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Side-by-side comparison against top Healthcare peers.